TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy

BACKGROUND: Doxorubicin (DOX) is an anthracycline antibiotic that inhibits the growth of several solid and hematologic malignant tumors. Increasing the targeting ability of DOX and reducing the multi-drug resistance (MDR) of tumor cells to DOX are major aims for researchers. PURPOSE: In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lan, Jiang, Wenhui, Wu, Lan, Yu, Xiaolan, He, Zheng, Shan, Weiguang, Fu, Lulu, Zhang, Zhenhai, Zhao, Yunchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647655/
https://www.ncbi.nlm.nih.gov/pubmed/34880613
http://dx.doi.org/10.2147/IJN.S335405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647655/
https://www.ncbi.nlm.nih.gov/pubmed/34880613
http://dx.doi.org/10.2147/IJN.S335405

Ejemplares similares